SCHEMBL20029653

SCHEMBL20029653

CC(C)CCC(C)(C)OC(=O)n1ccc(OCC2(C(F)(F)F)CC2)n1

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CFTR P13569 18/20 0.37
ACACB O00763 1/20 0.34
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20023965 0.85 CFTR (0.39) CFTR
SCHEMBL20029455 0.81 CFTR (0.40) CFTR
SCHEMBL20029658 0.79 CFTR (0.40) CFTR
SCHEMBL21274809 0.78 CFTR (0.40) CFTR
SCHEMBL26809680 0.76 CFTR (0.33) CFTR
SCHEMBL20029801 0.75 CFTR (0.40) CFTR
SCHEMBL21245122 0.74 CFTR (0.36) CFTR
SCHEMBL22996171 0.74 CFTR (0.34) CFTR
SCHEMBL21245086 0.74 CFTR (0.32) CFTR
SCHEMBL21244472 0.73 CFTR (0.32) CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3519401-B1 MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR VERTEX PHARMA (US) 2021-09-29 EP disclosed
WO-2018064632-A1 MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-04-05 WO disclosed